21591 ⎘
Preparations containing radioactive substances for use in therapy or testing characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus; Organic compounds; Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins; Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody the antibody being against an enzyme
Radiolabelled Compounds
#2THERAPEUTIC AGENTS AND USES THEREOF
#3IMMUNOCONJUGATES COMPRISING KALLIKREIN RELATED PEPTIDASE 2 ANTIGEN BINDING DOMAINS AND THEIR USES
#4Fibroblast activation protein compound or salt with albumin dual-binding function
#5IIMMUNOCONJUGATES COMPRISING KALLIKREIN RELATED PEPTIDASE 2 ANTIGEN BINDING DOMAINS AND THEIR USES
#6NOVEL ANTIBODY SEQUENCES FOR DIAGNOSTICS AND THERAPEUTICS
#7COMBINATION RADIOTHERAPY
#8STEAP2-TARGETED COMPOUNDS AND USE THEREOF
#9ANTIBODIES AGAINST CAIX WITH REDUCED AFFINITY FOR THE NEONATAL FC RECEPTOR
#10NOVEL ANTI-MASP-2 ANTIBODIES
#11ANTI-FIBROBLAST ACTIVATION PROTEIN ANTIBODIES
#12Fibroblast Activation ImmunoPET for Detection of Fibrosis Activity
#13ANTIBODY FRAGMENT AGAINST FAP
#14MATERIALS AND METHODS FOR TREATING CORONAVIRUS
#15Granzyme B directed imaging and therapy
#16RADIOIMMUNOCONJUGATES AND CHECKPOINT INHIBITOR COMBINATION THERAPY
#17THERANOSTIC SYSTEM FOR DIRECTED DIFFUSION OF THERAPEUTIC AND IMAGING AGENTS TO CANCER CELLS
#18ANTIBODIES AGAINST CAIX WITH REDUCED AFFINITY FOR THE NEONATAL FC RECEPTOR
#19ANTIBODIES FOR BINDING PSMA WITH REDUCED AFFINITY FOR THE NEONATAL FC RECEPTOR
#20Anti-FAP antibodies and methods of use
#21RECOMBINANT FAP BINDING PROTEINS AND THEIR USE
#22THERAPEUTIC AGENTS AND USES THEREOF
#23Actinium-225 and checkpoint inhibitor combination therapy
#24Humanised Anti Kallikrein-2 Antibody
#25PHARMACEUTICAL PREPARATION
#26RADIOIMMUNOCONJUGATES AND CHECKPOINT INHIBITOR COMBINATION THERAPY
#27Anti-transglutaminase 2 antibodies
#28Anti-ERBB-2 antibodies and uses thereof
#29Antibodies and molecules derived therefrom that bind to STEAP-1 proteins
#30Method of treating renal cancer using carbonic anhydrase IX (G250) antibodies
#31THERAPEUTIC AGENTS AND USES THEREOF
#32Anti-FAP antibodies and methods of use
#33HER3 inhibitor for modulating radiosensitivity
#34RADIO-PHARMACEUTICAL COMPLEXES
#35Anti-PCSK9 antibody and use thereof
#36Granzyme B directed imaging and therapy
#37Humanised anti kallikrein-2 antibody
#38Anti-transglutaminase 2 antibodies
#39Carbonic anhydrase IX-specific antibodies and uses thereof
#40Selective reduction of the deleterious activity of extended tri-nucleotide repeat containing genes
#41Carbonic anhydrase IX (G250) antibodies and methods of use thereof
#42Antibodies specific for urokinase-type plasminogen activator and methods of use thereof for treating cancer
#43Antibodies and molecules derived therefrom that bind to STEAP-1 proteins
#44IMMUNO-PET IMAGING OF ANTIBODIES AND IMMUNOCONJUGATES AND USES THEREFOR
#45Humanised anti kallikrein-2 antibody
#46Radio-imaging and radio-therapy of cancer using antibodies to HAAH
#47Therapeutic Agents and Uses Thereof
#48Picolinate cross-bridged cyclams, chelates with metallic cations and use thereof
#49METHODS AND COMPOSITIONS FOR IMAGING DISORDERS USING POLYSPECIFIC AGENTS
#50DIAGNOSIS OF PROSTATE CANCER
#51Antibodies specific for urokinase-type plasminogen activator and methods of use thereof
#52IMMUNO-PET IMAGING OF ANTIBODIES AND IMMUNOCONJUGATES AND USES THEREFOR
#53Selective reduction of the deleterious activity of extended tri-nucleotide repeat containing genes
#54Methods for identifying agents useful for modulating the expression and aggregation of CAG-expanded gene product in cells
#55PHARMACEUTICAL PREPARATION
#56Anti-FAP antibodies and methods of use
#57Anti-FAP antibodies and methods of use
#58DIAGNOSIS OF PROSTATE CANCER
#59Method of treating cancer by administering chimeric antigen receptor comprising anti-GCC antibody
#60INACTIVE N-ACETYLATED-ALPHA-LINKED ACIDIC DIPEPTIDASE-LIKE PROTEIN 2 (NAALADL2) AS A THERAPEUTIC AND DIAGNOSTIC TARGET
#61Antibodies and molecules derived therefrom that bind to STEAP-1 proteins
#62Anti-transglutaminase 2 antibodies
#63Compositions and methods for identifying and targeting cancer cells of alimentary canal origin
#64HER3 inhibitor for modulating radiosensitivity
#65Chimeric T cell receptor comprising carbonic anhydrase IX (G250) antibody
#66Methods for modulating the expression and aggregation of a CAG-expanded gene product in cells and methods for identifying agents useful for doing the same
#67Selective reduction of the deleterious activity of extended tri-nucleotide repeat containing genes
#68Anti-GCC antibody molecules
#69Antibodies and molecules derived therefrom that bind to STEAP-1 proteins
#70Antibodies Against A Cancer-Associated Epitope of Variant HNRNPG and Uses Thereof
#71Compositions and methods for identifying and targeting cancer cells of alimentary canal origin
#72SELECTIVE DETECTION OF BONE METASTASES IN RENAL CLEAR CELL CARCINOMA
#73Methods for modulating the expression and aggregation of CAG-expanded gene product in cells and methods for identifying agents useful for doing the same
#74Antibodies and methods of use thereof
#75Anti-FAP antibodies and methods of use
#76Method for treating breast cancer using antibody binding to MMP-14
#77Compositions and Methods for Identifying and Targeting Cancer Cells of Alimentary Canal Origin
#78Compositions and methods for identifying and targeting cancer cells of alimentary canal origin
#79COMPOSITIONS AND METHODS FOR IDENTIFYING AND TARGETING CANCER CELLS OF ALIMENTARY CANAL ORIGIN
#80Antibodies against a cancer-associated epitope of variant HnRNPG and uses thereof
#81Metalloproteinase binding proteins
#82COMPOSITIONS AND METHODS FOR IDENTIFYING AND TARGETING CANCER CELLS OF ALIMENTARY CANAL ORIGIN
#83Compositions and methods for identifying and targeting cancer cells of alimentary canal origin
#84Carbonic anhydrase IX (G250) anitbodies
#85Antibodies and molecules derived therefrom that bind to STEAP-1 proteins
#86COMPOSITIONS AND METHODS FOR IDENTIFYING AND TARGETING CANCER CELLS OF ALIMENTARY CANAL ORIGIN
#87Antibodies that bind MMP-14
#8814094, a novel human trypsin family member and uses thereof
#89Antibodies and/or conjugates thereof which bind to the amino terminal fragment of urokinase, compositions and uses thereof
#90Detection of CDX2 expression
#91Compositions and methods for identifying and targeting cancer cells of alimentary canal origin
#92Compositions and methods for identifying and targeting cancer cells of alimentary canal origin